๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Assay for Tetracycline HC1 and Chlortetracycline HCl in Tetracycline HC1

โœ Scribed by Woolford, Mason H. ;Chiccarelli, Fortunato S.

Publisher
Elsevier
Year
1956
Weight
166 KB
Volume
45
Category
Article
ISSN
0095-9553

No coin nor oath required. For personal study only.

โœฆ Synopsis

evaluation of other dosage forms and routes of administration.

For drugs not exhibiting this type of elimination rate, other mathematical or graphical expressions may be derived to define the elimination process in terms of useful biologic paramieters. When this is possible by means of drug blood levels or other experimental approach, the information should be especially valuable in the planning of dosage forms and regimens. 3. REFERENCES ( I ) Lapp, C..

๐Ÿ“œ SIMILAR VOLUMES

Comparison of the PapilloCheckยฎ assay wi
Comparison of the PapilloCheckยฎ assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes
โœ Marie-Noelle Didelot; Nathalie Boulle; Audrey Damay; Valรฉrie Costes; Michel Sego ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB

## Abstract The PapilloCheckยฎ assay was compared with the Digene HC2 HPV DNA assay for the detection of 13 highโ€risk human papillomaviruses (HPV) in 240 samples, including 181 cervical scrapes and 59 anal scrapes. Overall, 75 (30.5%) samples were positive by the Digene HC2 HPV DNA assay: 34 (18.8%)

Evaluation of the tetracycline-repressib
Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines
โœ Gschwend, Jรผrgen E.; Fair, William R.; Powell, C. Thomas ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 330 KB ๐Ÿ‘ 2 views

## BACKGROUND. Studies of genes that may inhibit growth or induce death of cells are facilitated greatly by tightly controlled expression of those genes. A promising system for control of transgene expression over a wide range is the tetracycline-repressible transactivator (tTA) system developed b

Microtoxicology. VI. Identification and
Microtoxicology. VI. Identification and differentiation of the newer antihistaminic drugs related to benadryl, pyribenzamine, and antergan*,โ€ โ€ The authors wish to thank Merck and Co. for the Neoantergan Maleate; Nepera Chemical Co., Inc. for the Neoheteramine HC1; G. D. Searle and Co. for the Dramamine; Wm. S. Merrell and Co. for the Decapryn Succinate; Parke, Davis and Co. for the Linadryl HCI; and Ciba Pharmaceutical Products, Inc. for the Antistine HCI and No. 204 HCI used in this study.
โœ Haley, Thomas J. ;Keenan, George L. ๐Ÿ“‚ Article ๐Ÿ“… 1949 ๐Ÿ› Elsevier โš– 458 KB